13
clinical trials: IMMPACT recommendations.
J Pain
9(2): 105-121,
2/2008.
Food and Drug Administration. Guidelines for Industry (draft).
Patient-Reported Outcome Measures: Use in Medical Product
Development to Support Labeling Claims. 2006. Rockville MD,
U.S. Department of Health and Human Services.
Ref Type: Report
Klepstad P, Loge JH, Borchgrevink PC, Mendoza TR, Cleeland CS,
Kaasa S. The Norwegian Brief Pain Inventory questionnaire:
translation and validation in cancer pain patients.
J Pain
Symptom Manage
24(5): 517-525, 11/2002.
Melzack R. The McGill Pain Questionnaire: major properties and
scoring methods.
Pain
1(3): 277-299, 9/1975.
Melzack R, Casey KL. Sensory, motivational, and central control
determinants of pain: a new conceptual model. In: Kenshalo
DR, editor.
The Skin Senses Proceedings
. Springfield IL: Thomas;
pp. 423-439, 1968.
Mendoza T, Mayne T, Rublee D, Cleeland C. Reliability and validity
of a modified Brief Pain Inventory short form in patients with
osteoarthritis.
Eur J Pain
10(4): 353-361, 5/2006.
Mendoza TR, Chen C, Brugger A, Hubbard R, Snabes M, Palmer SN,
Zhang Q, Cleeland CS. The utility and validity of the modified
Brief Pain Inventory in a multiple-dose postoperative analgesic
trial.
Clin J Pain
20(5): 357-362, 9/2004.
Radbruch L, Loick G, Kiencke P, Lindena G, Sabatowski R, Grond S,
Lehmann KA, Cleeland CS. Validation of the German version of
the Brief Pain Inventory.
J Pain Symptom Manage
18(3): 180-
187, 9/1999.
Saxena A, Mendoza T, Cleeland CS. The assessment of cancer
pain in north India: the validation of the Hindi Brief Pain
Inventory--BPI-H.
J Pain Symptom Manage
17(1): 27-41, 1/1999.
Turk DC, Dworkin RH, Allen RR, Bellamy N, Brandenburg N, Carr DB,
Cleeland CS, Dionne R, Farrar JT, Galer BS, Hewitt DJ, Jadad
AR, Katz NP, Kramer LD, Manning DC, McCormick CG,
McDermott MP, McGrath P, Quessy S, Rappaport BA, Robinson
14
JP, Royal MA, Simon L, Stauffer JW, Stein W, Tollett J, Witter J.
Core outcome domains for chronic pain clinical trials:
IMMPACT recommendations.
Pain
106: 337-345, 2003.
Turk DC, Dworkin RH, Burke LB, Gershon R, Rothman M, Scott J,
Allen RR, Atkinson JH, Chandler J, Cleeland C, Cowan P,
Dimitrova R, Dionne R, Farrar JT, Haythornthwaite JA, Hertz S,
Jadad AR, Jensen MP, Kellstein D, Kerns RD, Manning DC,
Martin S, Max MB, McDermott MP, McGrath P, Moulin DE,
Nurmikko T, Quessy S, Raja S, Rappaport BA, Rauschkolb C,
Robinson JP, Royal MA, Simon L, Stauffer JW, Stucki G, Tollett J,
von ST, Wallace MS, Wernicke J, White RE, Williams AC, Witter J,
Wyrwich KW. Developing patient-reported outcome measures
for pain clinical trials: IMMPACT recommendations.
Pain
125(3):
208-215, 12/2006.
